Hironori Hozoji
Corporate Officer/Principal chez Jafco Life Science Investment Ltd.
Profil
Mr. Hironori Hozoji is Investment Officer at Jafco Life Science Investment Ltd.
and Independent Director at TRACON Pharmaceuticals, Inc. He is on the Board of Directors at TRACON Pharmaceuticals, Inc. and Complexa, Inc.
Mr. Hozoji was previously employed as Independent Director by KYTHERA Biopharmaceuticals, Inc. and a Principal by JAFCO Co., Ltd.
He also served on the board at Eagle Pharmaceuticals, Inc., Affymax, Inc., The Artisan Co. LLC, Agensys, Inc., Artisan Pharma, Inc., LigoCyte Pharmaceuticals, Inc. and Singulex, Inc.
He received his undergraduate degree from Meiji University.
Postes actifs de Hironori Hozoji
| Sociétés | Poste | Début |
|---|---|---|
| Jafco Life Science Investment Ltd. | Corporate Officer/Principal | 01/07/2012 |
Anciens postes connus de Hironori Hozoji
| Sociétés | Poste | Fin |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 31/03/2015 |
| EAGLE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2013 |
| KYTHERA BIOPHARMACEUTICALS INC | Directeur/Membre du Conseil | 14/12/2012 |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Directeur/Membre du Conseil | 01/07/2012 |
| AFFYMAX, INC. | Directeur/Membre du Conseil | 28/02/2007 |
Formation de Hironori Hozoji
| Meiji University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| JAFCO GROUP CO., LTD. | Finance |
| AFFYMAX, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
| LigoCyte Pharmaceuticals, Inc. | Health Technology |
| The Artisan Co. LLC | |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Health Services |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
| Jafco Life Science Investment Ltd. |
